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We evaluated whether genital inflammation affects the selection
of the transmitted virus. Among South African women, we
found that preinfection genital inflammation facilitates trans-
mission of less infectious human immunodeficiency virus, but
highly infectious viruses are able to establish infection regard-
less of inflammation status. This suggests that viral phenotype
can influence transmission risk.
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A severe genetic bottleneck is observed during heterosexual
human immunodeficiency virus (HIV) transmission; in ap-
proximately 80% of cases, only a single viral variant will estab-
lish infection, despite the diverse viral population in the donor
[1, 2].This transmitted founder virus is rarely the dominant var-
iant, suggesting that transmission is not entirely stochastic but
favors certain viral phenotypes [3–5]. The most likely determi-
nants of this bottleneck are the physical and immunological
properties of the healthy genital mucosa, which constitutes an
efficient barrier to HIV acquisition and is able to block most un-
protected sexual exposures [6]. Genital inflammation has been
shown to increase the risk of HIV acquisition [7] and may result
in infection with multiple viral variants [2]. However, the im-
pact of inflammation on the characteristics of viruses that estab-
lish infection has not yet been established.
We hypothesized that a healthy genital mucosa confers a
stringent barrier to HIV infection, allowing only the most infec-
tious viruses to establish infection. The presence of
inflammation, which potentially compromises the epithelial
barrier and recruits activated HIV target cells, may enable less
infectious variants to establish infection. We investigated this
possibility by measuring the infectivity of recently transmitted
viruses and relating this to cytokine concentrations in preinfec-
tion cervicovaginal lavage (CVL) samples. To our knowledge,
our study is the first to show that preinfection genital inflamma-
tion can affect the selection of the transmitted viral phenotype
by facilitating transmission of less infectious HIV.
METHODS
Participants
Acute HIV infection plasma and preinfection CVL samples
were obtained from 27 women enrolled in the Centre for the
AIDS Programme of Research in South Africa (CAPRISA)
004 tenofovir gel trial [8]. The Research Ethics Committees of
the Universities of KwaZulu-Natal and Cape Town approved
this study, and participants provided written informed consent.
Cytokine Measurement
Concentrations of interleukin 1α, 1β, 6, 7, 8, and 10 (IL-1α,
IL-1β, IL-6, IL-7, IL-8, and IL-10), granulocyte-macrophage
colony-stimulating factor, interferon γ–inducible protein 10,
monocyte chemoattractant protein 1, macrophage inflammato-
ry protein (MIP) 1α, MIP-1β, and tumor necrosis factor (TNF)
α were measured in CVL samples, as described elsewhere, using
Milliplex Human Cytokine kits (Millipore) [7].
Virus Isolation and Generation of Pseudoviruses
Virus was isolated from plasma using µMACS VitalVirus HIV
isolation kits according to protocol (Miltenyi Biotec). Single ge-
nome env amplicons were generated from these isolates, cloned
into pcDNA3.1D/V5-His TOPO (Invitrogen)according to the
manufacturer’s instructions, and cotransfected with the subtype
B backbone vector pSG3Δenv (National Institutes of Health
AIDS Reagent Program; catalog No. 11051) into HEK 293T
cells to generate pseudoviruses (PSVs) (Supplementary
Material).
Viral Infectivity
Viral isolates and PSVs were serially diluted and added to
TZM-bl cells in the presence or absence of 20 µg/mL diethyla-
minoethyl (DEAE)–dextran (Sigma). Luciferase activity was
quantified 48 hours later, and viral infectivity was calculated
as relative light units (RLUs) generated per picogram of re-
verse-transcriptase (RT) activity (RLUs/pg RT) in each stock,
as measured with the Roche colorimetric RT assay.
Statistical Analysis
Unsupervised hierarchical clustering was used to cluster women
according to their cytokine profiles. Linear regression was used
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to examine the relationship between cytokines, cytokine factor
scores, and viral infectivity (Supplementary Material). P values
were adjusted for multiple comparisons using a false discovery
rate step-down procedure.
RESULTS
HIV isolates were obtained a median of 34 days after infection
from plasma of 27 women who seroconverted during the CAP-
RISA 004 trial [8] (Supplementary Table 1). Viral infectivity was
quantified using the TZM-bl, assay and hierarchical clustering
was used to group women according to their preinfection cervi-
covaginal cytokine profiles, measured a median of 4.6 months
before infection (range, 0.5–13.5 months). Women with higher
genital cytokine levels were more likely to be infected by viruses
with lower infectivity (Figure 1A). A cytokine profile including
TNF-α, MIP-1α, IL-7, and IL-10 significantly separated women
according to the infectivity of their viral isolates (Supplementa-
ry Figure 1).
The relationships between individual cytokines and viral in-
fectivity were then investigated using linear regression to ana-
lyze RLUs/pg RT as a continuous variable and adjust for
potential confounders, including study arm, time between in-
fection and virus isolation, age, hormonal contraceptive use,
viral tropism, subtype, sex acts per month, and herpes simplex
virus 2 status (Supplementary Tables 1 and 2). To reduce the
complexity of the data set, we also used confirmatory factor
analysis to group cytokines into factors, including all 12 cyto-
kines, proinflammatory cytokines only (IL-1α, IL-1β, IL-6,
and TNF-α), and chemokines (IL-8, interferon γ–inducible
protein 10, monocyte chemoattractant protein 1, MIP-1α,
MIP-1β). After adjustment for confounders, the factor includ-
ing all cytokines, the proinflammatory factor, and IL-1β, IL-6,
IL-7, and IL-10 were inversely associated with viral infectivity
(Figure 1B; Supplementary Figure 2).
We then classified women according to the level of inflam-
mation in their genital tracts. To estimate baseline levels, we in-
cluded cytokine data for 54 HIV-uninfected controls, because
these women were shown elsewhere to have lower levels of in-
flammation than women who later became infected [7]. We
found that only 2 of 11 women (18%) who did not have prein-
fection genital inflammation were infected by viruses with low
infectivity (RLUs/pg RT below the median), compared with 11
of 16 (69%) with inflammation (Figure 1C). Interestingly, fewer
women with genital inflammation (5 of 16; 31%) than without
inflammation (9 of 11; 82%) were infected by highly infectious
viruses (RLUs/pg RT at or above the median). Similar results
were obtained when comparing women infected by the most
highly infectious viruses (RLUs/pg RT at ≥75th percentile)
with those infected by viruses with very low infectivity
(RLUs/pg RT at <25th percentile) (Supplementary Figure 3).
Because viral infectivity is the sum of multiple steps in the
viral life cycle, we evaluated whether the first step, viral entry,
was driving the relationship with genital inflammation. We
found an association between genital inflammation and the
DEAE-dextran dependency of the isolates (Supplementary Fig-
ure 4), as well as the PSV infectivity (Supplementary Figure 5),
suggesting that viral entry efficiency may be the main driver.
Next we examined whether genital inflammation affects the
genetic bottleneck by allowing for the transmission of multiple
viral variants as opposed to a single virus. Although this finding
was not significant (Fisher exact test; P = .10), of the 27 women
studied, all 4 multivariant transmissions were detected in
women grouped as having inflammation. Furthermore, the che-
mokine factor score and MIP-1α concentrations were higher in
women with multiple transmitted viral variants (Figure 1D).
Finally, we found that viral infectivity was not associated with
markers of HIV disease progression, including plasma viral load
set point (β coefficient, −0.55 (95% confidence interval, −1.37
to .27; P = .18)] and time taken for CD4+ T cell counts to fall to
<350/µL or antiretroviral therapy initiation (hazard ratio, 0.40;
95% confidence interval, .12–1.31; P = .13), even after adjust-
ment for genital inflammation.
DISCUSSION
HIV prevalence in young South African women is extremely
high, yet the biological factors driving this prevalence are not
well understood. One important factor could be the high prev-
alence of inflammatory genital conditions that increase HIV ac-
quisition risk [7]. In the current study, we showed that in the
absence of preinfection genital inflammation most women be-
came infected by highly infectious viruses. However, in women
with inflammation, an increase in HIV infections was observed,
which primarily involved viruses of low infectivity. This sug-
gests that a healthy genital mucosa provides an effective barrier
against less infectious viruses, which can be compromised by
genital inflammation. The transmission probability of a virus
would thus depend not only on the efficiency of the mucosal
barrier and viral concentration in semen [6] but also on viral
phenotype.
Interestingly, we also found that fewer women with preinfec-
tion genital inflammation were infected by highly infectious vi-
ruses, compared with women without inflammation. This could
suggest that within the viral quasispecies in semen or within the
infected population, less infectious viruses might outnumber
those with higher infectivity.
Our findings are in line with those of former studies showing
that transmitted founder viruses exhibit higher infectivity than
chronic viruses [9] and that genital ulceration or inflammation
can reduce the selection bias for consensuslike variants during
transmission, allowing for less fit viruses to establish infection
[3]. In contrast, Deymier et al [4] did not observe selection for
higher infectivity in a study of 6 transmission pairs, although
this could be due to the use of DEAE-dextran in their infectivity
assay and/or the presence of subclinical inflammation. The
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Figure 1. Preinfection genital inflammation was associated with acquisition of less infectious human immunodeficiency virus (HIV). A, Unsupervised hierarchical clustering was
used to visualize the variation in cytokine concentrations in individual women and to cluster women according to the similarities of their cytokine expression profiles (using Qlucore
Omics Explorer software, version 3.0). Women from whom less infectious viruses were isolated (value below median for relative light units per picogram of reverse-transcriptase
[RLUs/pg RT]; n = 13; green blocks) had up-regulated cytokine concentrations in preinfection cervicovaginal lavage (CVL) samples and tended to cluster together. Women from whom
highly infectious viruses were isolated (RLUs/pg RT at or above the median) had lower cytokine concentrations and also clustered together (n = 14; yellow blocks). Cytokine con-
centrations are indicated using a color scale, ranging from blue (low) to red (high). The dendrogram above the heat map illustrates degrees of relatedness between genital cytokine
profiles evident among the various women. Patient identity numbers are indicated below the heat map. B, RLUs/pg RT and cytokine concentrations were either log10-transformed or
converted to categorical variables (MIP-1α, MIP-1β, GM-CSF, and IL-7), and β coefficients were calculated using linear regression. Factor scores for each functional group of
cytokines were generated using confirmatory factor analysis. Circles indicate β coefficients from regression analyses; error bars, 95% confidence intervals. Black circles indicate
associations between cytokine factors and RLUs/pg RT that were statistically significant (unadjusted P < .05); gray circles, associations between individual cytokines and infectivity
that were statistically significant before adjustment for multiple comparisons. Regression analyses were adjusted for potential confounders, including tenofovir or placebo assign-
ment, virus subtype, tropism, time between infection and virus isolation, age, hormonal contraceptive use, number of sex acts per month, and herpes simplex virus 2 status. C, To
estimate baseline levels of inflammation, cytokine factor scores including all 12 cytokines were calculated for 27 HIV-infected women and 54 uninfected controls. Women with
cytokine scores at or above the median were considered to have genital inflammation, and those with scores less than the median did not. High- and low-infectivity viruses were
defined as those with RLUs/pg RT at or above the median or below the median, respectively. P values were calculated using the Fisher exact test. GTI, genital tract inflammation.
D, Relationship between cytokines and multiple variant transmission. Box-and-whisker plots show medians with ranges of cytokine concentrations and factor scores. Mann–
Whitney U test was used to compare cytokine concentrations and factor scores between women infected by single (n = 23; white boxes) or multiple (n = 4; gray boxes) HIV variants.
*Statistically significant before but not after adjustment for multiple comparisons. †Statistically significant (cytokine factors) or significant after adjustment for multiple comparisons
(cytokines). P values for cytokine comparisons were adjusted for multiple comparisons using a false discovery rate step-down procedure. Abbreviations: GM-CSF, granulocyte-
macrophage colony-stimulating factor; IL-1α, IL-1β, IL-6, IL-7, IL-8, and IL-10, interleukin 1α, 1β, 6, 7, 8, and 10; IP, interferon γ–inducible protein; MCP, monocyte chemoattractant
protein; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor.
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genital cytokines that predicted transmission of less infectious
viruses, including proinflammatory IL-1β, IL-6, TNF-α, and he-
matopoietic IL-7, have been shown to directly induce HIV ex-
pression [10], whereas at lower concentrations, IL-10 synergizes
with inflammatory cytokines to enhance HIV replication [11].
The chemokine MIP-1α recruits CCR5+ cells needed to estab-
lish infection [12].
A limitation of the current study is the relatively small num-
ber of isolates that had matching preinfection CVL samples
available for cytokine analysis. Although few of the women
were infected by multiple viral variants, limiting the statistical
power, multivariant transmission was correlated with higher
genital MIP-1α levels and higher chemokine factor scores, sug-
gesting a possible role for target cell recruitment in multivariant
transmission. We did not find an association between viral in-
fectivity and disease progression, suggesting that other host fac-
tors, such as immune activation, also contribute to disease
progression or that infectivity does not confer a long-term ad-
vantage. In conclusion, our results show that genital inflamma-
tion before infection can affect the transmitted viral phenotype
by facilitating transmission of less infectious HIV variants.
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